Medical Research
(H123)
IRS Verified
DX Registered
990 on File
THE WUNDERGLO FOUNDATION
Financial strength (30%)
56/100
Reliability (20%)
50/100
Effectiveness (25%)
63/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
The WunderGlo Foundation will not rest until there is a cure for colon cancer. The Foundation strives to save lives and support cancer warriors everywhere by raising funds for colon cancer research, promoting awareness about prevention of and treatment for colon cancer, and encouraging healthy lifestyle choices. Through its efforts, the WunderGlo Foundation seeks to empower and inspire those fighting the disease and those finding ways to eradicate it.
Financial Overview — FY 2024
$191K
Total Revenue
$183K
Total Expenses
$117K
Net Assets
2
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
55.3%
Fundraising Efficiency
102.5%
Operating Reserve
7.67x
Liability-to-Asset
2.2%
Revenue Diversification
103.9%
Executive Compensation
$60K
Compared with Peers
FY 2024
Compared with 727 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
55.3% | 84.5% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
25.3% | 11.4% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
19.4% | 0.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
102.5% | 10.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
7.7 mo | 13.5 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
2.2% | 0.4% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
103.9% | 93.3% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
-14.5% | 9.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-15.1% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
4.5% | 1.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $191K | $183K | $117K | 55.3% | 2 |
| 2023 | $224K | $215K | $208K | 63.7% | 2 |
| 2022 | $278K | $304K | $200K | 77.6% | 2 |
| 2021 | $289K | $197K | N/A | — | 2 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.